Registration

NVG, LLC for ASTELLAS PHARMA US, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Healthcare policy; medical innovation issues.

LobbyistCovered position, as disclosed
IRENE BUENO New Legis. Asst., Sen. Cranston; Spec. Asst. to Asst. Secy for Legislation, HHS; Dep. Asst. Secy for Legislation, HHS; Spec. Asst. to the President, White House
LISA GERMAN FOSTER New Senior Policy Advisor, Senator Jack Reed
ANDREA LARUE New Rules Committee Counsel, Senator Christopher Dodd; Counsel, Senator Thomas A. Daschle; Legislative Assistant & District Director, Congressman Michael A. Andre
EDEN SHIFERAW New —

Health Issues HCR

Healthcare policy; medical innovation issues.

LobbyistCovered position, as disclosed
IRENE BUENO New Legis. Asst., Sen. Cranston; Spec. Asst. to Asst. Secy for Legislation, HHS; Dep. Asst. Secy for Legislation, HHS; Spec. Asst. to the President, White House
LISA GERMAN FOSTER New Senior Policy Advisor, Senator Jack Reed
ANDREA LARUE New Rules Committee Counsel, Senator Christopher Dodd; Counsel, Senator Thomas A. Daschle; Legislative Assistant & District Director, Congressman Michael A. Andre
EDEN SHIFERAW New —

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ASTELLAS PHARMA, INC. Japan Japan 99.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.